|
|
|
Volumn 35, Issue 2, 2013, Pages 103-108
|
|
[Small molecule inhibitor SB203580 enhances the antitumor effect of gefitinib in PC-9 and A549 lung cancer cell lines].
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
4 (4 FLUOROPHENYL) 2 (4 METHYLSULFINYLPHENYL) 5 (4 PYRIDYL)IMIDAZOLE;
ANTINEOPLASTIC AGENT;
ENZYME INHIBITOR;
GEFITINIB;
IMIDAZOLE DERIVATIVE;
MITOGEN ACTIVATED PROTEIN KINASE P38;
PROTEIN KINASE B;
PYRIDINE DERIVATIVE;
QUINAZOLINE DERIVATIVE;
ADENOCARCINOMA;
APOPTOSIS;
ARTICLE;
CELL CYCLE;
CELL PROLIFERATION;
DRUG ANTAGONISM;
DRUG EFFECT;
DRUG POTENTIATION;
HUMAN;
LUNG ADENOCARCINOMA;
LUNG TUMOR;
METABOLISM;
PATHOLOGY;
PHOSPHORYLATION;
SIGNAL TRANSDUCTION;
TUMOR CELL LINE;
ADENOCARCINOMA;
ANTINEOPLASTIC AGENTS;
APOPTOSIS;
CELL CYCLE;
CELL LINE, TUMOR;
CELL PROLIFERATION;
DRUG SYNERGISM;
ENZYME INHIBITORS;
HUMANS;
IMIDAZOLES;
LUNG NEOPLASMS;
P38 MITOGEN-ACTIVATED PROTEIN KINASES;
PHOSPHORYLATION;
PROTO-ONCOGENE PROTEINS C-AKT;
PYRIDINES;
QUINAZOLINES;
SIGNAL TRANSDUCTION;
|
|
EID: 84886709768
PISSN: 02533766
EISSN: None
Source Type: None
DOI: None Document Type: Article |
|
Times cited : (6)
|
|
References (0)
|
